HYEX
Price
$2.00
Change
+$0.20 (+11.11%)
Updated
Jul 25 closing price
Capitalization
19.36M
KAYS
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
1.24M
Interact to see
Advertisement

HYEX vs KAYS

Header iconHYEX vs KAYS Comparison
Open Charts HYEX vs KAYSBanner chart's image
HEALTHY EXTRACTS
Price$2.00
Change+$0.20 (+11.11%)
Volume$1.24K
Capitalization19.36M
Kaya Holdings
Price$0.02
Change-$0.00 (-0.00%)
Volume$68.75K
Capitalization1.24M
HYEX vs KAYS Comparison Chart in %
Loading...
HYEX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KAYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HYEX vs. KAYS commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYEX is a Hold and KAYS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (HYEX: $2.00 vs. KAYS: $0.02)
Brand notoriety: HYEX and KAYS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HYEX: 133% vs. KAYS: 442%
Market capitalization -- HYEX: $19.36M vs. KAYS: $1.24M
HYEX [@Pharmaceuticals: Other] is valued at $19.36M. KAYS’s [@Pharmaceuticals: Other] market capitalization is $1.24M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYEX’s FA Score shows that 0 FA rating(s) are green whileKAYS’s FA Score has 1 green FA rating(s).

  • HYEX’s FA Score: 0 green, 5 red.
  • KAYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KAYS is a better buy in the long-term than HYEX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYEX’s TA Score shows that 7 TA indicator(s) are bullish while KAYS’s TA Score has 4 bullish TA indicator(s).

  • HYEX’s TA Score: 7 bullish, 2 bearish.
  • KAYS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HYEX is a better buy in the short-term than KAYS.

Price Growth

HYEX (@Pharmaceuticals: Other) experienced а +11.11% price change this week, while KAYS (@Pharmaceuticals: Other) price change was -45.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYEX($19.4M) has a higher market cap than KAYS($1.24M). HYEX YTD gains are higher at: -20.316 vs. KAYS (-27.321). KAYS (-1.42M) and HYEX (-1.44M) have comparable annual earnings (EBITDA) . HYEX has more cash in the bank: 213K vs. KAYS (30.5K). HYEX has less debt than KAYS: HYEX (1.08M) vs KAYS (7.66M). HYEX has higher revenues than KAYS: HYEX (2.32M) vs KAYS (545K).
HYEXKAYSHYEX / KAYS
Capitalization19.4M1.24M1,566%
EBITDA-1.44M-1.42M101%
Gain YTD-20.316-27.32174%
P/E RatioN/A0.70-
Revenue2.32M545K425%
Total Cash213K30.5K698%
Total Debt1.08M7.66M14%
FUNDAMENTALS RATINGS
HYEX vs KAYS: Fundamental Ratings
HYEX
KAYS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6196
P/E GROWTH RATING
1..100
542
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HYEX's Valuation (87) in the null industry is in the same range as KAYS (93). This means that HYEX’s stock grew similarly to KAYS’s over the last 12 months.

HYEX's Profit vs Risk Rating (100) in the null industry is in the same range as KAYS (100). This means that HYEX’s stock grew similarly to KAYS’s over the last 12 months.

HYEX's SMR Rating (100) in the null industry is in the same range as KAYS (100). This means that HYEX’s stock grew similarly to KAYS’s over the last 12 months.

HYEX's Price Growth Rating (61) in the null industry is somewhat better than the same rating for KAYS (96). This means that HYEX’s stock grew somewhat faster than KAYS’s over the last 12 months.

KAYS's P/E Growth Rating (2) in the null industry is somewhat better than the same rating for HYEX (54). This means that KAYS’s stock grew somewhat faster than HYEX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HYEXKAYS
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 18 days ago
69%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
HYEX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KAYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAPL22.180.06
+0.27%
CrossAmerica Partners LP
MAC17.64N/A
N/A
Macerich Company (The)
ONC291.47-4.99
-1.68%
BeOne Medicines Ltd
DSX1.63-0.03
-1.81%
Diana Shipping
LITM4.74-0.27
-5.39%
Snow Lake Resources Ltd

HYEX and

Correlation & Price change

A.I.dvisor tells us that HYEX and CLCFF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYEX and CLCFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYEX
1D Price
Change %
HYEX100%
+11.11%
CLCFF - HYEX
6%
Poorly correlated
N/A
SHIEF - HYEX
3%
Poorly correlated
N/A
GEDSF - HYEX
1%
Poorly correlated
N/A
LVZPF - HYEX
0%
Poorly correlated
N/A
KAYS - HYEX
-0%
Poorly correlated
-13.40%
More

KAYS and

Correlation & Price change

A.I.dvisor tells us that KAYS and KMDA have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KAYS and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAYS
1D Price
Change %
KAYS100%
-13.40%
KMDA - KAYS
20%
Poorly correlated
-0.77%
AYRWF - KAYS
6%
Poorly correlated
+2.78%
UPC - KAYS
5%
Poorly correlated
+4.92%
VRNOF - KAYS
3%
Poorly correlated
+13.55%
KKPCF - KAYS
2%
Poorly correlated
N/A
More